key: cord-0919062-wf5uiz0w
authors: Pierros, Vasileios; Kontopodis, Evangelos; Stravopodis, Dimitrios J.; Tsangaris, George Th.
title: Unique peptide signatures of SARS-CοV-2 virus against human proteome reveal variants’ immune escape and infectiveness
date: 2022-04-04
journal: Heliyon
DOI: 10.1016/j.heliyon.2022.e09222
sha: 5261b1638f746c48049e2ad517ffd28a8f24b073
doc_id: 919062
cord_uid: wf5uiz0w

SARS-CoV-2 pandemic has necessitated the identification of sequence areas in the viral proteome that are capable to serve as antigenic sites and treatment targets. In the present study, we have applied a novel approach for mechanistically illuminating the virus-host organism interactions, by analyzing the Unique Peptides (UPs) of the virus featured by a minimum amino acid sequence length being defined as Core Unique Peptides (CrUPs), not of the virus per se, but against the entire proteome of the host organism. This approach resulted in the identification of CrUPs of the virus itself, which could not be recognized in the host organism proteome. Thereby, we analyzed the SARS-CoV-2 proteome for identification of CrUPs against the human proteome, which have been defined as C/H-CrUPs. We herein reveal that SARS-CoV-2 include 7.503 C/H-CrUPs, with the SPIKE_SARS2 being detected as the protein with the highest density of C/H-CrUPs. Extensive analysis has indicated that the critical P681R mutation produces new C/H-CrUPs around the R685 cleavage site, while the L452R mutation causes loss of antigenicity of the NF9 peptide and strong(er) binding of the virus to its ACE2 receptor protein. Simultaneous formation of these mutations in detrimental variants like Delta leads to the immune escape of the virus, its massive entrance into the host cell, a notable increase in virus formation, and its massive release and thus elevated infectivity of human target cells.

Covid-19 pandemic has emerged the urgent necessity of the identification of sequence sites of the SARS-CoV-2 viral proteome that can serve as appropriate treatment targets and antigenic positions suitable for production of therapeutic vaccines.

As we have recently described, a Unique Peptide (UP) is defined as the peptide carrying an amino acid sequence that appears only in one of all proteins in a particular proteome. To this direction, our team has also introduced, for the first time, the concept of Core Unique Peptide (CrUP), which represents the peptide bearing a minimum length of amino acid sequence that resides solely in one of all proteins in a profiled proteome, thereby rendering it a unique signature for identification and differential recognition of a given protein (Alexandridou et al., 2009; Kontopodis et al., 2019) . Hence, to thoroughly map the UP-specific landscape of a proteome of interest, we have developed a novel bioinformatics tool that is based on advanced algorithms being dedicated to big-data analysis. Its engagement to deep and accurate processing of the 20.430 reviewed Homo sapiens (human) proteins led to the recognition and identification of more than 7x10 6 CrUPs, which represent the backbone of human Uniquome that is mainly described as the voluminous collection of UPs shaping the human proteome (Kontopodis et al., 2022 and Kontopodis et al. manuscript in preparation) .

Most importantly, to further illuminate the mechanisms controlling virus-host interactions, we have recently developed a novel, dynamic and advanced bioinformatics platform to thoroughly analyze and compare virus-derived CrUPs against host-organism proteome(s). This unique collection contains peptides that notably differ from the virusspecific CrUPs themselves, with each one of them being described as the peptide carrying an amino acid sequence of minimum length that is accommodated exclusively in one out of all proteins throughout the viral proteome. These virus against host CrUPs bear two cardinal properties: first, they are unique in virus proteome and, second, they do not exist in host-organism proteome. Therefore, the virus against host proteome-derived CrUPs can advance our knowledge and understanding of virus-host interactions, and virus infectiveness and pathogenicity dynamics. Furthermore, they can be used as diagnostic and antigenic peptides, and likely therapeutic targets, as well. Altogether, these CrUPs seem to represent a completely new entity of peptides capable to significantly improve our view and comprehension regarding the structuring, functioning and mapping of virus and human Uniquomes, and their proteomic "cross-talks", towards immune escape and infectiveness (Kontopodis et al., 2022) .

Since human cells can host the SARS-CoV-2 virus, we have herein engaged our novel bioinformatics platform not only for the profiling of CrUPs in the SARS-CoV-2 proteome per se, but, most importantly, for their identification against the human proteome (C/H-CrUPs). Remarkably, C/H-CrUPs can likely serve as targets for the immune response upon infection, and antigenic sites with major pharmaceutical and diagnostic potential, for the successful clinical management of Covid-19 pandemic.

The SARS-CoV-2 proteome is structurally quite simple. In the UNIPROT database (version 7/2021), 16 reviewed and 75.714 unreviewed proteins have been included (Jungreis et al., 2021) . For the present study, only the 16 reviewed proteins are examined, since the unreviewed proteome components contain (among others) duplicate registrations, and unverified sequences and protein fragments, which could lead to unreliable data regarding the uniqueness of a protein sequence.

To recognize all the CrUPs being embraced in the SARS-CoV-2 proteome against the human proteome, we in silico constructed a new, artificial, "hybrid-proteome" that contained all the reviewed human proteins (20.430 proteins), plus the one protein derived from the SARS-CoV-2 viral proteome (20.431 proteins). Thus, 16 "hybrid proteomes" including the 16 SARS-CoV-2 proteins were constructed. Hence, these "hybrid proteomes" were bioinformatically searched one by one for the identification of SARS-CoV-2-specific CrUPs in human protein sequence environments (C/H-CrUPs). Strikingly, 7.503 C/H-CrUPs were detected, with 4.213 of them being presented one time in the SARS-CoV-2 proteome, 3.289 being observed two times in the viral proteome and only one peptide ("VNNATN") with a 6 amino acid length being recognized three times (Table 1) . Data processing and analysis unveiled that C/H-CrUPs retain a length range from 4 to 9 amino acids, while longer peptides could not be identified in the SARS-CoV-2 virus proteome. Length distribution showed that the majority of C/H-CrUPs have a 6 amino acid length, whereas only one with 4 amino acids and only two with 9 amino acids C/H-CrUPs were observed (Fig. 1) .

The distribution of C/H-CrUPs across SARS-CoV-2 proteins demonstrated that the Replicase Polyprotein 1ab (R1AB_SARS2), which is the longest viral protein consisted of 7.096 amino acids, produces almost half of the identified C/H- CrUPs (5.334; 49, 3%) J o u r n a l P r e -p r o o f 5 (Table 2) . On the other hand, the Putative ORF3b protein (ORF3B_SARS2), with a length of 22 amino acids, produces only 15 C/H-CrUPs that show a protein density of 68%.

Notably, Spike glycoprotein (SPIKE_SARS2) is presented with the highest C/H-CrUPs density (78%), thus indicating its intriguing feature to carry the highest number of C/H-CrUPs (987), in terms of their physical length, as opposed to the ORF3c protein (ORF3C_SARS2), which is characterized by a respective density of only 56% (Table 2) .

A typical example for the construction of C/H-CrUPs is the peptide "PDEDEEEGD". This peptide is a 9 amino acid in length C/H-CrUP that belongs to Replicase polyprotein 1a (R1A_SARS2), starting at position 927 and ending at position 935 (Fig. 2) . Around this peptide, 8 C/H-CrUPs were recognized with a 5-7 amino acid length range.

In order to illuminate the mechanisms orchestrating the differential pathologies of SARS-CoV-2 compared to other coronavirus family members, we, next, applied the same strategy to other two similar viruses, the Severe Acute Respiratory Syndrome CoronaVirus (SARS-CoV) and the Middle East Respiratory Syndrome-related CoronaVirus (MERS-CoV). Among human viruses, SARS-CoV-2 (C) together with SARS-CoV (S) and MERS-CoV (M) constitute the β coronavirus group, and they use the same cellular receptor, the Angiotensin-Converting Enzyme 2 (ACE2), with SARS-CoV-2 sharing approximately 80 and 70% amino acid sequence identity with SARS-CoV and MERS-CoV, respectively (Saputri et al., 2020; Walls et al., 2020) . SARS-CoV viral proteome includes 15 reviewed proteins, while MERS-CoV contains 10 reviewed proteins in the UNIPROT database. Our findings confirm the strong similarities among these three coronaviruses at the level of CrUP structure and architecture against human proteome.

Interestingly, a more comprehensive analysis of CrUPs per protein has revealed significant differences between them. The density of M/H-CrUPs per protein ranges between 71-76% (5% range), the density of S/H-CrUPs per protein varies between 61-76% (15% range) and the density of C/H-CrUPs per protein fluctuates between 56-78% (22% range) (Table 2) , thus indicating the comparatively more heterogenous CrUPs density in the SARS-CoV-2 coronaviral proteome.

Among all SARS-CoV-2 proteins, the SPIKE_SARS2 (P0DTC2) one (Spike) has received the greatest attention as a key element for virus attachment to the host cell, and J o u r n a l P r e -p r o o f as such it has become a principal target for therapeutic vaccine development Xia 2021) . To mechanistically couple protein's molecular features with virus pathology at the level of C/H-CrUPs, we comparatively analyzed the Spike proteins of the three coronaviruses, and, next, we projected the findings onto SPIKE_SARS2 mutation map. Spike glycoprotein presents a length of 1.273 amino acids in SARS-CoV-2, 1.275 amino acids in SARS-CoV and 1.373 amino acids in MERS-CoV (Agrawal et al., 2021) .

Their densities in CrUPs against the human proteome are measured as 78, 76 and 76%, respectively, exhibiting the highest CrUP density values among all proteins for each virus herein studied (Table 2) . Amino acid sequence alignment of SPIKE_SARS2 (P0DTC2), SPIKE_SARS (P59594) and R9UQ53_MERS (R9UQ53) proved that these three viral Spike proteins share a group of 12 regions, herein defined as Universal Peptides (UPs) ( Fig. 3 and Table 3 ). The majority of coronaviral UPs are clustered in the S2 domain of each Spike protein, with a critical one of them (UPs) containing the Furin cleavage site 3 (R 815 ↓S).

Most importantly, SARS-CoV-2 Spike protein has presented a significant mutational diversity (Sanches et al., 2021; Tzou et al., 2020) . Hitherto, 9 main variants with adaptive mutations and high spread to human populations, named from Alpha to Lambda, respectively, have been thoroughly mapped and characterized. These 9 variants are divided in 39 sub-variants, while other 32 sporadic variants have also been described (Tzou et al., 2020) . To investigate the association of mutational profiling with C/H-CrUP landscaping of SARS-CoV-2 Spike protein, the 39 sub-variants together with the wild-type Spike protein (SPIKE_SARS2, P0DTC2) were suitably aligned (Fig. 4A ).

This multiple alignment illustrates all the herein identified UPs (Table 3 ) and all the mutations previously announced per isolated variant (Fig. 4B) . Notably, it seems that almost all the hitherto characterized mutations are identified in regions being located outside the UPs group. Their majority are clustered in the S1 domain of Spike protein, with two critical mutations being detected in the S1-S2 bridge region, at the amino acid residue 681 that resides in proximity to the first cleavage position by Furin protease, in between the 685 th and 686 th amino acid residue ( Fig. 4C ) (Davidson et al., 2020; Coutard et al., 2020) .

Remarkably, all the examined mutations herein prove to create new CrUPs against the human proteome compared to the wild-type Spike protein, thus indicating that the mutant virus strains need novel clinical treatments. This is an important finding, since J o u r n a l P r e -p r o o f 7 these new C/H-CrUPs do not exist in the human proteome, but are observed exclusively in the mutant virus proteomes, thereby justifying the great attention Alpha, Delta, Kappa, Lambda and Mu variants have recently received at the worldwide level (Tzou et al., 2020) . Table 3 lists all the novel C/H-CrUPs being created by the hitherto reported mutations in coronavirus variants. These variants include 25 mutations, which produce 44 new CrUPs against the human proteome. It may be these novel C/H-CrUPs that give rise to formation of new Intrinsically Disordered Regions (IDRs) and Small Linear Motifs (SLiMs) in the SARS-CoV-2 Spike protein mutant versions (van der Lee et al., 2014; Hraber et al., 2020) .

The molecular mechanism of Spike protein's proteolytic activation has been shown to play a crucial role in the selection of host species, virus binding to the ACE2 receptor, virus-cell fusion, and viral infection of human lung cells (Peacock et al., 2021; Whittaker 2021; Shang et al., 2020a) . Spike protein contains three cleavage sites: the R 685 ↓S and the R 815 ↓S positions that serve as direct targets of Furin protease, and the T 696 ↓M position that can be recognized by TMPRSS2 protease (Hoffmann et al., 2020a; Hoffmann et al., 2020b; Takeda, 2021) . Analysis of the wild-type C/H-CrUPs and the new formed, mutation-induced, C/H-CrUPs in Spike protein unveiled that the mutation-driven, novel, peptides are created exclusively around the critical R 685 ↓S cleavage site by the two pathogenic mutations P681H and P681R (Table 4) .

Notably, among these four new peptides (Table 4 ), the only one that embraces Furin's cleavage site is the "SRRRAR↓S" C/H-CrUP, which is solely generated by the P681R mutation carried by the Delta and Kappa coronavirus variants, while at the same time the "PRRARSV" peptide maintains its uniqueness even after the replacement of Proline (P) with Arginine (R) and its transformation to "RRRARSV" (Figs. 5A and B).

The Furin cleavage site R 685 ↓S has been characterized as a 20 amino acid sequence motif that corresponds to the amino acid sequence A672-S691 of the Spike protein (Figs. 4A and B) (Wu and Zhao, 2020) . The 8 amino acid sequence peptide "SPRRAR↓SV" (S680-V687) serves as the core region of the motif, while two flanking solvent-accessible regions of 8 amino acids (A672-N679) and 4 amino acids (A688-S691) long, respectively, are recognized (Takeda, 2021; Wu and Zhao, 2020) .

Pro-protein Convertase (PC) Furin and/or Furin-like PCs act as sequence-specific proteases and can cleave the Spike protein in a position recognizing the unique, and positively charged by the Arginine, motif "R-x-x-R↓S" (Wu and Zhao, 2020) . Since Furin and/or Furin-like PCs are secreted from host cells and bacteria in the airway epithelium, J o u r n a l P r e -p r o o f while other PCs, such as PC5/6A and PACE4, exhibit widespread tissue distribution, it is likely that their activities may be critically implicated in the SARS-CoV-2-induced damage and pathology of multiple infected organs (Örd et al., 2020) . It seems that Furin's cleavage site essentially contributes to the infection process and disease progression, and offers a powerful target for immunogenetic, antigenic and therapeutic interventions, as strongly supported by the recently developed new antibody against Furin's cleavage site (Braun et al., 2019; Zahradník et al., 2021; Wu et al., 2020) .

Most importantly, the SARS-CoV-2 Delta variant that carries the critical mutation P681R seems to be more infectious and pathogenic than the wild-type virus form, while the importance of this mutation has very recently begun to be recognized (Wu et al., 2020) . Replacement of Proline (P) with Arginine (R) at position 681 causes the loss of amino acid sequence uniqueness that characterizes the wild-type "PRRARSV" C/H-CrUP and likely increases the possibility of Furin's cleavage site (core region) to be significantly stabilizing its conformation, thus facilitating a more efficient Spike protein cleavage process by the Furin protease (Whittaker, 2021; Callaway, 2021) .

To the same direction, novel SLiMs, such as "SRRR", "RRR", "RRRAR" and "RRRARS", can be produced by the mutant C/H-CrUPs, which may act as specific targets of other than Furin PCs, thereby enabling the stronger (and quicker) binding of the mutant virus to its host ACE2 receptor, which likely leads to a comparatively more generalized infection and massive mutant virus production (Table 5 ) (Shorthouse et al., 2021; Davey et al., 2015) . This finding seems to be evidenced by the remarkable increase of the total number of motifs created by the P681R mutation identified within the human proteome (Table 5) . Of note, the mutant C/H-CrUP-derived new SLiMs, in the SARS-CoV-2 Delta variant, could render Spike protein antigenically weak or defective, fostering it to lose its capacity to serve as antibody target and thus promoting the virus immune escape (Davey et al., 2015; Almehdi et al., 2021) .

An important issue for viral infectivity and pathogenesis is the receptor recognition and binding of the virus to the host cell surface. SARS-CoV-2 belongs to the β coronavirus group and, like SARS-CoV, uses the same cellular receptor, the Angiotensin-Converting Enzyme 2 (ACE2) (Walls et al., 2020; Wang et al., 2020) . The SARS-CoV-2 Spike protein attaches to ACE2 receptor by a Receptor-Binding Domain (RBD) defined in the Spike protein from positions F318 up to F541 (Shang et al., 2020b) . Nowadays, this region has J o u r n a l P r e -p r o o f received great attention, as it seems to be the target of antibodies against the virus and other therapeutic interventions (Chen et al., 2021; Zahradník et al., 2021; Hastie et al., 2021) . Additional studies have shown that from the amino acid residue W436 up to the Q506 one the RBD contains the Receptor-Binding Motif (RBM), which carries 12 contact positions with ACE2 (Hatmal et al., 2020) . Mutation analysis revealed that in 10 positions of the RBD region 13 mutations were described ( Fig. 4 and Table 6 ). In RBM, 10 mutations in 6 sequence positions were reported for different virus variants (Table 6) , while from the 10 contact positions only the P501Y in Alpha, Beta, Gamma and Mu variants was found to be mutated.

The most important region in RBM is the peptide "NYNYLYRLF" (from 448 to 456 position). This Tyrosine (Y)-enriched peptide contains two contact site (Y449 and Y453) and it is known as the NF9 peptide (Motozono et al., 2021) . It seems to affect antigen recognition, by being an immunodominant HLA*24:02-restricted epitope identified by the CD8 + T-cells. Furthermore, NF9 stimulation also increases cytokine production by the CD8 + T-cells, such as IFN-γ, TNF-α and IL-2 (Kared et al., 2021) . Analysis of C/H-CrUPs that are being associated with the NF9 peptide showed that it contains 3 UPs ( Fig. 5D and E, and Table 7 ). Mutation analysis indicated that in the NF9 peptide the mutation L452R is carried by the variants Alpha, Delta, Lamda and Kappa, while the mutation L452Q appears in the variant Lambda. Further analysis unveiled that these mutations are observed in the amino acid that resides at position 5, exactly in the middle of the peptide, creating 3 and 4 new C/H CrUPs, respectively (Table 8) . These mutations have a dramatic effect in the uniqueness of the NF9 peptide(s). Namely, the 6 amino acid length C/H-CrUPs "NYNYLY" lose their uniqueness against the human proteome, while only by the mutation L452Q a new CrUP with 5 amino acid length is surprisingly created ( Fig. 5D and E, and Table 8 ). The loss of uniqueness of this peptide, which notably is located at the beginning of NF9 peptide, seems to be crucial, as it leads to the loss of antigenic capacity of the NF9 peptide, thus evading the HLA-A24-restricted immunity and inducing the immune escape of the virus. Interestingly, related studies have shown that the L452R mutation (and subsequently the new created C/H-CrUPs herein characterized) increases the infectiveness of SARS-CoV-2, by strengthening the electrostatic interactions of this region on Spike protein with the ACE2 virus receptor (Motozono et al., 2021) .

Hitherto, epidemiological data indicated that the dominant variant of SARS-CoV-2 is the Delta variant (Micochova et al., 2021) . Under the light of the aforementioned J o u r n a l P r e -p r o o f findings, variant's enhanced pathogenicity seems to be the outcome of the simultaneous presence (accumulation) of two critical mutations, the L452R and P681R ones, in Delta variant. The mutation L452R, through the loss of NF9 peptide uniqueness, causes virus immune escape and strong(er) binding of the virus to its cognate receptor, while at the same time the mutation P681R facilitates the Spike protein cleavage process by different proteases, inducing a generalized infection and a massive virus release. Therefore, the Delta variant gains a significant advantage of escape from the immune system per se, as well as from the vaccination-induced immunity, together with an increased infectiveness as a result of virus entrance into the host cell, and an increase of virus formation and its massive release.

Since mutations outside the Spike protein locus in SARS-CoV-2 coronavirus genome have not been yet completely mapped, in a systematic manner, our study importantly reveals novel and useful information of all the remaining, Spike proteinindependent, C/H-CrUPs that seem to hold strong promise and open new therapeutic windows for the Covid-19 pandemic. Finally, the approach of virus-host UP-specific signature identification could prove a useful tool for the elucidation of virus infectiveness, prevention of virus immune escape, domination of pathogenic variants, and identification of new antigenic and pharmacological targets.

A new bioinformatics tool that has been recently built on an advanced big-data algorithm was herein developed to extract CrUP collections from proteomes of interest and, thereby, create organism-specific Uniquomes. The user can specify the min and max peptide lengths that the tool will analyze. The tool will split each protein to all possible peptides of length min to length max, thus generating a very large set of peptides (for a protein of length L with a window of size W, a set of "C = L -W + 1" will be generated). In the next step, all these peptides, starting from smallest and ending to largest, will be searched against the rest of the proteome to decide whether the peptide exists on another J o u r n a l P r e -p r o o f protein or not. Since the search is dedicated for the smallest possible peptide (Core Unique Peptide: CrUP), the tool will first make sure that the peptide under examination does not already contain a smaller CrUP. This is ensured by examining if any of the already identified CrUPs of the protein is contained within the peptide under examination.

All peptides that conform to these two rules are considered as CrUPs. Figure 6 describes the algorithm we have herein developed and used to recognize these novel CrUPs.

In Figure 7 , a sliding window of 9 amino acids is applied on O00400 ACATN_HUMAN protein, generating the candidate peptides "VYVKNFGRR" and "YVKNFGRRK". These peptides will be searched against the rest of the proteome, to determine their uniqueness once we have ensured that they do not already contain a smaller CrUP. The latter is determined by examining whether an already defined CrUP is included within the peptide.

To address the question of the present study, the aforementioned tool was expanded by developing a new feature, where the user can give a reference and a target proteome. This new feature allows the tool to search all the peptides of the target proteome against the reference proteome, thus creating a set of CrUPs of target versus reference proteome. To this direction, the tool (similar to the initial implementation) will split all proteins in the target proteome to all possible peptides of length min to length max. Now, instead of searching for the uniqueness of each peptide within the same proteome, it performs that search against the reference proteome. Like before, the peptide under examination must not contain any smaller peptides already identified as CrUPs. The algorithm we have employed to identify these CrUPs is described diagrammatically in Figure 6 .

For Motif and SLiM identification, and search, the tool offers the user the ability to perform a motif search to identify putative SLiMs. User gives an N-length peptide, as well as the number of amino acids that can vary in the given peptide. Then, the tool creates all possible combinations of peptides that can be produced by considering in each combination exactly N-amino acid(s) as unknown. Once these combinations are produced, an exhaustive search using regular expressions is performed against the reference proteome, to locate all possible proteins containing such peptides. To better highlight the process, if the user provides the peptide "TQYILG" and N = 2, the following combinations will be generated: • TQYI??

User will receive a list of all proteins containing peptides that match the criteria, including the motif against which the peptide was matched, and all the positions within the protein sequence where that peptide can be found. All proteomes were taken from the UNIPROT database.

To recognize all the CrUPs being embraced in a virus proteome against the human proteome, we in silico constructed a new, artificial, "hybrid-proteome" that contained all the reviewed human proteins (20.430 proteins), plus the one protein derived from the viral proteome (20.431 proteins). Thereby, n "hybrid proteomes", including the n viral proteins, were constructed, with n representing the number of viral proteins. Hence, these "hybrid proteomes" were bioinformatically searched one by one for the identification of virusspecific CrUPs in human protein sequence environments. The proteome of the virus constituted the β coronavirus group SARS-CoV-2, SARS-CoV and MERS-CoV were analyzed for core unique peptides against the human proteome. The CrUPs of each virus against the Human proteome were presented (C/H-CrUPs). The identified C/H-CrUPs were further analyzed for the times by which they appeared in the virus proteome. The C/H-CrUPs density, is defined as the percentage of the total Amino Acids contained in C/H-CrUPs of each virus to the total number of the virus Amino Acids. The proteome of the virus constituted the β coronavirus group SARS-CoV-2, SARS-CoV and MERS-CoV were analyzed for core unique peptides against the human proteome. The CrUPs of each virus against the Human proteome were presented (C/H-CrUPs). The identified C/H-CrUPs were further analyzed for the times by which they appeared in the virus proteome. The C/H-CrUPs density, is defined as the percentage of the total Amino Acids contained in C/H-CrUPs of each virus to the total number of the virus Amino Acids. The analysis of the SARS-CoV-2, SARS-CoV and MERS-CoV virus is presented. All viruses' proteins were analyzed and each protein is shown by its EntryID, Entry Name and Protein Name according to the UNIPTOT data base. The AA length of each protein and the CrUPs of each protein against the human proteome are shown. Density is defined as the percentage of the total Amino Acids contained in CrUPs of each protein to the total number of the protein's Amino Acids. The analysis of the SARS-CoV-2, SARS-CoV and MERS-CoV virus is presented. All viruses' proteins were analyzed and each protein is shown by its EntryID, Entry Name and Protein Name according to the UNIPTOT data base. The AA length of each protein and the CrUPs of each protein against the human proteome are shown. Density is defined as the percentage of the total Amino Acids contained in CrUPs of each protein to the total number of the protein's Amino Acids.

The Universal peptides of SARS-CoV-2, SARS-CoV and MERS-CoV spike proteins according to Fig. S2 presented alignment. The position in the protein sequence and the peptide sequence are shown. Green blocks indicated the common Amino Acids in all proteins, * indicated positions with different Amino Acids between proteins. Next the CrUP included in the Universal Peptides are recorded followed by the domain of the spike protein in which they belong. Yellow blocks indicated complete sequence CrUP appeared in the Universal peptide in all spike proteins alignment. 

The Universal peptides of SARS-CoV-2, SARS-CoV and MERS-CoV spike proteins according to Fig. 4Β . The position in the protein sequence and the peptide sequence are shown. * indicated positions with different Amino Acids between spike proteins. Next the CrUP included in the Universal Peptides are recorded followed by the domain of the spike protein in which they belong. Yellow blocks mark the C/H-CrUPs appeared in the Universal peptide in all spike proteins.

J o u r n a l P r e -p r o o f 

The Universal peptides of SARS-CoV-2, SARS-CoV and MERS-CoV spike proteins according to Fig. 4Β . The position in the protein sequence and the peptide sequence are shown. * indicated positions with different Amino Acids between spike proteins. Next the CrUP included in the Universal Peptides (UnPs) are recorded followed by the domain of the spike protein in which they belong. Yellow blocks mark the C/H-CrUPs appeared in the UnPs in all spike proteins. J o u r n a l P r e -p r o o f The C/H-CrUPs created by the mutations in the Receptor-Binding domain of SARS-CoV-2 wild-type and mutant spike protein (SPIKE_SARS2, P0DTC2) were identified. Peptide number/peptide length is the number of a given length C/H-CrUP around the position. By red color the amino acids in wild-type C/H-CrUPs which will be replaced and the mutated amino acids in the new C/H-CrUPs were marked. Light blue color marks the peptides which disappeared by wild type virus by the mutation, yellow color marks the completely newly created peptides by the mutation. 

J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f The C/H-CrUPs created by the mutations in the Receptor-Binding domain of SARS-CoV-2 wild-type and mutant spike protein (SPIKE_SARS2, P0DTC2) were identified. Peptide number/peptide length is the number of a given length C/H-CrUP around the position. By red color the amino acids in wild-type C/H-CrUPs which will be replaced and the mutated amino acids in the new C/H-CrUPs were marked. Light blue color marks the peptides which disappeared by wild type virus by the mutation, yellow color marks the completely newly created peptides by the mutation.

Exploration of antigenic determinants in spike glycoprotein of SARS-CoV2 and identification of five salient potential epitopes

UniMaP: finding unique mass and peptide signatures in the human proteome

SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies

Furin-mediated protein processing in infectious diseases and cancer

The mutation that helps Delta spread like wildfire

ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

Short linear motifs -ex nihilo evolution of protein regulation

Characterization of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein

Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

Resources to Discover and Use Short Linear Motifs in Viral Proteins

SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes

SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals

Data processing approach for the construction and evaluation of an organism's UNIQUOME with comparative analysis for the Human, Rat and Mouse Uniquomes. Paper presented at XIII. Annual Congress of the European Proteomics Association: From Genes via Proteins and their Interactions to Functions

2022) Prediction of SARS-CoV-2 Omicron variant immunogenicity, immune escape and pathogenity, through the analysis of spike protein-specific core unique peptides. Vaccines

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity

The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV

Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion

The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets

Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom)

Gamma (P.1, Brazil) and Delta (B.1.617.2, India)

Flexible, Functional, and Familiar: Characteristics of SARS-CoV-2 Spike Protein Evolution

Cell entry mechanisms of SARS-CoV-2

Structural basis of receptor recognition by SARS-CoV-2

SARS-CoV-2 variants are selecting for spike protein mutations that increase protein stability

Proteolytic activation of SARS-CoV-2 spike protein

An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds

Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

SARS-CoV-2 spike and its adaptable furin cleavage site

Furin cleavage sites naturally occur in coronaviruses

Furin: A Potential Therapeutic Target for COVID-19. iScience

Domains and Functions of Spike Protein in SARS-CoV-2 in the Context of Vaccine Design

SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution

J o u r n a l P r e -p r o o f